Literature DB >> 29243516

Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease.

Mattia Bellan1,2, Pier Paolo Sainaghi3,4, Margherita Tran Minh1,3, Rosalba Minisini1, Luca Molinari1,5, Marco Baldrighi1,5, Livia Salmi1, Matteo Nazzareno Barbaglia1, Luigi Mario Castello1,5, Paolo Ravanini6, Gian Carlo Avanzi1,5, Mario Pirisi1,3,4.   

Abstract

AIM: Plasma Gas6 was tested as an alternative to Baveno VI criteria (liver stiffness <20 kPa and platelet count >150 × 109/l) in an endoscopy-sparing strategy.
METHODS: A total of 160 patients with chronic hepatitis C and advanced fibrosis/cirrhosis underwent, on the same occasion, liver elastography, upper endoscopy, a platelet count and serum Gas6 measurement.
RESULTS: A total of 74/160 (46%) patients had esophageal varices, that were small (diameter <5 mm) in 57/160 (34%) and large in 17/160 (11%) cases. A total of 34/160 (21%) patients satisfied Baveno VI criteria, according to which screening for esophageal varices could have been omitted; 1/34 had large varices (sensitivity 94%). A plasma Gas6 value <45 ng/ml, detected in 34/160 (21%) patients, was also 94% sensitive.
CONCLUSION: Plasma Gas6 might represent a feasible alternative to Baveno VI criteria when transient elastography is unavailable/unsuccessful.

Entities:  

Keywords:  Gas6; cirrhosis; esophageal varices

Mesh:

Substances:

Year:  2017        PMID: 29243516     DOI: 10.2217/bmm-2017-0171

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  8 in total

1.  Baveno Criteria Safely Identify Patients With Compensated Advanced Chronic Liver Disease Who Can Avoid Variceal Screening Endoscopy: A Diagnostic Test Accuracy Meta-Analysis.

Authors:  Zsolt Szakács; Bálint Erőss; Alexandra Soós; Péter Mátrai; Imre Szabó; Erika Pétervári; Judit Bajor; Nelli Farkas; Péter Hegyi; Anita Illés; Margit Solymár; Márta Balaskó; Patrícia Sarlós; Ákos Szűcs; József Czimmer; Áron Vincze; Gabriella Pár
Journal:  Front Physiol       Date:  2019-08-13       Impact factor: 4.566

Review 2.  Gas6/TAM Axis in Sepsis: Time to Consider Its Potential Role as a Therapeutic Target.

Authors:  Livia Salmi; Francesco Gavelli; Filippo Patrucco; Marina Caputo; Gian Carlo Avanzi; Luigi Mario Castello
Journal:  Dis Markers       Date:  2019-08-14       Impact factor: 3.434

Review 3.  Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis.

Authors:  Mattia Bellan; Micol Giulia Cittone; Stelvio Tonello; Cristina Rigamonti; Luigi Mario Castello; Francesco Gavelli; Mario Pirisi; Pier Paolo Sainaghi
Journal:  Int J Mol Sci       Date:  2019-10-12       Impact factor: 5.923

4.  Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders.

Authors:  Mattia Bellan; Arnaldo Dimagli; Cristina Piccinino; Ailia Giubertoni; Aurora Ianniello; Federico Grimoldi; Maurizio Sguazzotti; Alessandra Nerviani; Michela Barini; Alessandro Carriero; Carlo Smirne; Michela Emma Burlone; Cristina Rigamonti; Rosalba Minisini; Livia Salmi; Matteo Nazzareno Barbaglia; Luigi Mario Castello; Daniele Sola; Paolo Marino; Gian Carlo Avanzi; Mario Pirisi; Pier Paolo Sainaghi
Journal:  Dis Markers       Date:  2020-05-12       Impact factor: 3.434

Review 5.  New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis.

Authors:  Sara Pagani; Mattia Bellan; Daniele Mauro; Luigi Mario Castello; Gian Carlo Avanzi; Myles J Lewis; Pier Paolo Sainaghi; Costantino Pitzalis; Alessandra Nerviani
Journal:  Dis Markers       Date:  2020-01-19       Impact factor: 3.434

Review 6.  Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented Review.

Authors:  Mattia Bellan; Luigi Mario Castello; Mario Pirisi
Journal:  J Clin Transl Hepatol       Date:  2018-07-02

Review 7.  Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis.

Authors:  Carlo Smirne; Cristina Rigamonti; Carla De Benedittis; Pier Paolo Sainaghi; Mattia Bellan; Michela Emma Burlone; Luigi Mario Castello; Gian Carlo Avanzi
Journal:  Dis Markers       Date:  2019-09-08       Impact factor: 3.434

8.  Contrast-Enhanced CT May Be a Diagnostic Alternative for Gastroesophageal Varices in Cirrhosis with and without Previous Endoscopic Variceal Therapy.

Authors:  Qianqian Li; Ran Wang; Xiaozhong Guo; Hongyu Li; Xiaodong Shao; Kexin Zheng; Xiaolong Qi; Yingying Li; Xingshun Qi
Journal:  Gastroenterol Res Pract       Date:  2019-10-20       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.